Among the classes of pharmaceutics whose efficacy is influenced by CYP2D6 variants, there are compounds that can be used in the clinical management of individuals with PMS, like antidepressants, antipsychotics, and epileptics (Table 1). The gene discussed is CYP2D6; the disease is premenstrual tension.